Private Capital Advisors, Inc. - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 142 filers reported holding TRILLIUM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.

Quarter-by-quarter ownership
Private Capital Advisors, Inc. ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$133,000
-63.6%
12,419
-50.0%
0.02%
-66.2%
Q4 2020$365,000
-83.2%
24,839
-83.1%
0.07%
-90.4%
Q3 2016$2,167,000
+838.1%
146,633
+486.5%
0.77%
+650.5%
Q1 2016$231,000
-96.2%
25,000
-94.7%
0.10%
-96.0%
Q4 2015$6,003,000
-2.7%
476,069
-0.5%
2.59%
+0.4%
Q3 2015$6,169,000
-44.0%
478,569
-5.2%
2.58%
-28.1%
Q2 2015$11,010,000
+549.2%
504,562
+502.0%
3.59%
+481.7%
Q1 2015$1,696,00083,8200.62%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
NEA Management Company, LLC 2,100,000$646,0000.05%
Matrix Capital Management Company, LP 2,288,560$704,0000.02%
Tekla Capital Management LLC 446,099$137,0000.01%
Realta Investment Advisors 26,000$7,0000.00%
Virtu Financial LLC 34,991$11,0000.00%
Baker Brothers Advisors 505,262$155,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 20,044$6,0000.00%
MORGAN STANLEY 1,160,098$356,0000.00%
BANK OF MONTREAL /CAN/ 18,333$6,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 102,725$31,0000.00%
View complete list of TRILLIUM THERAPEUTICS INC shareholders